Malignant B cells in SLL/CLL have higher basal levels of phospho-proteins. Scatter plots of the basal level of 8 phospho-proteins in malignant B cells from SLL/CLL patients (SLL/CLL, n = 11), MZL patients (MZL, n = 3). Unstimulated samples were used for analysis of basal level of phospho-proteins. MFI for each phospho-protein in the CD20+CD5+ (SLL/CLL) or CD20+ subset (MZL) were normalized to MFI in the CD20+ B cell subset from healthy blood donor PBMC analyzed at the same time. * indicates significant change from normal CD 20+ B cells, p < 0.05; Wilcoxon Signed Rank test.
Blix et al. BMC Cancer 2012 12:478 doi:10.1186/1471-2407-12-478